Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Allogeneic”

3,294 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 3,294 results

Testing effectiveness (Phase 2)Study completedNCT00603954
What this trial is testing

Allogeneic HCT With HLA-matched Donors : a Phase II Randomized Study Comparing 2 Nonmyeloablative Conditionings

Who this might be right for
Hematological Malignancies
University of Liege 107
Testing effectiveness (Phase 2)Active Not RecruitingNCT05622318
What this trial is testing

De-escalated Cyclophosphamide (PTCy) and Ruxolitinib for Graft-versus-Host Disease (GVHD) Prophylaxis

Who this might be right for
Graft-versus-host Disease
Medical College of Wisconsin 56
Early research (Phase 1)Active Not RecruitingNCT04696731
What this trial is testing

Safety and Efficacy of ALLO-316 in Subjects With Advanced or Metastatic Clear Cell Renal Cell Carcinoma

Who this might be right for
Advanced/Metastatic Clear Cell Renal Cell Carcinoma
Allogene Therapeutics 120
Very early researchUnknownNCT04518774
What this trial is testing

Allogeneic "Gammadelta T Cells (γδ T Cells)" Cell Immunotherapy in Phase 1 Hepatocellular Carcinoma Clinical Trial

Who this might be right for
Hepatocellular Carcinoma
Beijing 302 Hospital 8
Testing effectiveness (Phase 2)WithdrawnNCT04720742
What this trial is testing

Immune Therapy and Analytical Treatment Interruption in HIV+ Participants Who Received an Allogeneic Stem Cell Transplantation

Who this might be right for
HIV Infection
IrsiCaixa
Testing effectiveness (Phase 2)Study completedNCT00262886
What this trial is testing

Donor Peripheral Stem Cell or Bone Marrow Transplant in Treating Patients With Relapsed or Refractory Metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
University of Rochester 35
Large-scale testing (Phase 3)Looking for participantsNCT04184505
What this trial is testing

Feasibility of Allogeneic Stem Cell Transplantation in Higher-risk-MDS (ACROBAT)

Who this might be right for
High-risk MDS
Gruppo Italiano Malattie EMatologiche dell'Adulto 274
Testing effectiveness (Phase 2)Study completedNCT03169231
What this trial is testing

Phase IIb Trial to Evaluate Longeveron Mesenchymal Stem Cells to Treat Aging Frailty

Who this might be right for
Aging Frailty
Longeveron Inc. 150
Not applicableStudy completedNCT01950286
What this trial is testing

Hyper-CVAD Treatment of Adult T-cell Acute Lymphoblastic Leukemia in Sweden.

Who this might be right for
T-cell Acute Lymphoblastic Leukemia
Region Örebro County 24
Testing effectiveness (Phase 2)Study completedNCT01487577
What this trial is testing

Pharmacokinetics-based Mycophenolate Mofetil Dosing for GVHD Prevention

Who this might be right for
Allogeneic Blood and Marrow Transplantation (BMT)Graft Versus Host Disease
University of Pittsburgh 19
Large-scale testing (Phase 3)Enrolling By InvitationNCT04275232
What this trial is testing

Allogenic Plasma Aliquots in the Treatment of Ligneous Conjunctivitis

Who this might be right for
Ligneous Conjunctivitis, Left Eye
Dorothy Bautista, MD 1
Not applicableStudy completedNCT03467087
What this trial is testing

Safety and Feasibility of Electrical Muscle Stimulation During Stem Cell Transplantation or Intensive Chemotherapy

Who this might be right for
Electric Stimulation Therapy
University Hospital, Saarland 45
Early research (Phase 1)Study completedNCT01535885
What this trial is testing

Using Multi-virus Cytotoxic T-cells Following T-Cell Depleted Allogeneic HPCT for Prophylaxis Against EBV, ADV, and CMV

Who this might be right for
Epstein-Barr Virus InfectionsAdenovirusCytomegalovirus Infections
Medical College of Wisconsin 25
Testing effectiveness (Phase 2)Looking for participantsNCT07368634
What this trial is testing

Exploratory Study of EBV-TCR-T Cell Injection for EBV DNAemia After Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Epstein-Barr Virus InfectionPost-Transplant Lymphoproliferative Disorder
Daihong Liu 18
Early research (Phase 1)Active Not RecruitingNCT07094464
What this trial is testing

Maintenance Therapy With Selinexor and Azacitidine in TP53 Mutant AML/MDS After Transplantation

Who this might be right for
TP53-mutated MDS and AMLAllogeneic Hematopoietic Stem Cell Transplantation
Daihong Liu 20
Early research (Phase 1)Looking for participantsNCT06760364
What this trial is testing

A Clinical Study of CHT102 in MSLN-Positive Advanced Pancreatic Cancer

Who this might be right for
Advanced Pancreatic Cancers
Tianjin Medical University Cancer Institute and Hospital 21
Testing effectiveness (Phase 2)Study completedNCT00003116
What this trial is testing

High-Dose Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+2 more
Case Comprehensive Cancer Center 66
Testing effectiveness (Phase 2)Ended earlyNCT03718533
What this trial is testing

Study of Efficacy and Safety of Eltrombopag in Patients With Poor Graft Function

Who this might be right for
Poor Graft Function
Novartis Pharmaceuticals 10
Testing effectiveness (Phase 2)Study completedNCT00002838
What this trial is testing

Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Refractory Chronic Lymphocytic Leukemia

Who this might be right for
Leukemia
M.D. Anderson Cancer Center 13
Testing effectiveness (Phase 2)UnknownNCT05066958
What this trial is testing

Ex-vivo Primed Memory Donor Lymphocyte Infusion to Boost Anti-viral Immunity After T-cell Depleted HSCT

Who this might be right for
Acute Myeloid LeukemiaHigh Risk Acute Myeloid LeukemiaAcute Lymphoblastic Leukemia, in Relapse+4 more
Federal Research Institute of Pediatric Hematology, Oncology and Immunology 20
Load More Results